Compare HRTX & CYCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HRTX | CYCU |
|---|---|---|
| Founded | 1983 | N/A |
| Country | United States | United States |
| Employees | N/A | 74 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.2M | 64.3M |
| IPO Year | 2007 | 2021 |
| Metric | HRTX | CYCU |
|---|---|---|
| Price | $0.36 | $2.19 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 218.2K |
| Earning Date | 11-03-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $154,904,000.00 | $17,771,485.00 |
| Revenue This Year | N/A | $13.37 |
| Revenue Next Year | N/A | $66.84 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $0.26 | $0.01 |
| 52 Week High | $1.58 | $15.52 |
| Indicator | HRTX | CYCU |
|---|---|---|
| Relative Strength Index (RSI) | 51.30 | 35.37 |
| Support Level | $0.29 | $0.03 |
| Resistance Level | $0.46 | $4.10 |
| Average True Range (ATR) | 0.04 | 0.28 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 52.02 | 4.69 |
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Cycurion Inc. provides information technology security solutions through its subsidiaries. The company continually strives to deliver top-notch services in risk management, cybersecurity, information assurance, systems engineering, and help desk solutions. The company has one reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information warfare and cybersecurity in the governmental and commercial markets. The company generates the majority of its revenue from Advisory Consulting services, with small portion revenue generated from Managed Security Service Practice (MSSP) and Software as a Service (Saas).